Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Accidental Falls | 57 | 2024 | 1055 | 7.120 |
Why?
|
Postural Balance | 40 | 2023 | 623 | 5.670 |
Why?
|
Hypotension, Orthostatic | 38 | 2024 | 258 | 5.330 |
Why?
|
Cerebrovascular Circulation | 37 | 2020 | 2757 | 4.660 |
Why?
|
Nursing Homes | 47 | 2023 | 1029 | 4.250 |
Why?
|
Aging | 76 | 2022 | 8613 | 3.540 |
Why?
|
Independent Living | 18 | 2023 | 559 | 3.460 |
Why?
|
Gait | 23 | 2023 | 781 | 3.450 |
Why?
|
Tai Ji | 13 | 2023 | 283 | 2.860 |
Why?
|
Blood Pressure | 77 | 2023 | 8554 | 2.820 |
Why?
|
Hypertension | 43 | 2023 | 8431 | 2.540 |
Why?
|
Geriatric Assessment | 36 | 2019 | 1366 | 2.510 |
Why?
|
Frail Elderly | 27 | 2019 | 690 | 2.330 |
Why?
|
Cognition | 36 | 2023 | 6686 | 2.180 |
Why?
|
Blood Flow Velocity | 19 | 2020 | 1437 | 2.130 |
Why?
|
Posture | 31 | 2023 | 966 | 2.070 |
Why?
|
Homes for the Aged | 21 | 2020 | 260 | 2.000 |
Why?
|
Syncope | 26 | 2023 | 431 | 1.940 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 705 | 1.870 |
Why?
|
Walking | 13 | 2023 | 1177 | 1.850 |
Why?
|
Ultrasonography, Doppler, Transcranial | 15 | 2020 | 302 | 1.780 |
Why?
|
Aged, 80 and over | 184 | 2023 | 57650 | 1.730 |
Why?
|
Aged | 299 | 2024 | 162698 | 1.680 |
Why?
|
Skilled Nursing Facilities | 9 | 2023 | 368 | 1.680 |
Why?
|
Activities of Daily Living | 30 | 2019 | 2410 | 1.520 |
Why?
|
Mobility Limitation | 7 | 2016 | 403 | 1.360 |
Why?
|
Videoconferencing | 5 | 2023 | 194 | 1.340 |
Why?
|
Antihypertensive Agents | 15 | 2022 | 2039 | 1.330 |
Why?
|
Middle Cerebral Artery | 13 | 2020 | 277 | 1.300 |
Why?
|
Hypotension | 19 | 2023 | 881 | 1.280 |
Why?
|
Cognition Disorders | 17 | 2017 | 4026 | 1.240 |
Why?
|
Regional Blood Flow | 6 | 2015 | 1528 | 1.200 |
Why?
|
Psychomotor Performance | 9 | 2021 | 1899 | 1.060 |
Why?
|
Male | 245 | 2023 | 349022 | 0.960 |
Why?
|
Disability Evaluation | 9 | 2019 | 1824 | 0.940 |
Why?
|
Housing for the Elderly | 4 | 2019 | 17 | 0.930 |
Why?
|
Autonomic Nervous System | 10 | 2012 | 670 | 0.920 |
Why?
|
Humans | 357 | 2024 | 739398 | 0.920 |
Why?
|
Foot | 11 | 2018 | 526 | 0.920 |
Why?
|
Female | 251 | 2023 | 378853 | 0.910 |
Why?
|
Geriatrics | 8 | 2023 | 396 | 0.890 |
Why?
|
Vascular Resistance | 10 | 2017 | 943 | 0.860 |
Why?
|
Somatosensory Disorders | 3 | 2012 | 47 | 0.860 |
Why?
|
Gait Disorders, Neurologic | 3 | 2021 | 230 | 0.860 |
Why?
|
Heart Rate | 30 | 2019 | 4095 | 0.850 |
Why?
|
Siderophores | 2 | 2015 | 56 | 0.850 |
Why?
|
Deferoxamine | 2 | 2015 | 153 | 0.840 |
Why?
|
Executive Function | 6 | 2020 | 1356 | 0.830 |
Why?
|
Long-Term Care | 12 | 2018 | 606 | 0.820 |
Why?
|
Infection Control | 4 | 2022 | 968 | 0.810 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2015 | 198 | 0.810 |
Why?
|
Health Education | 2 | 2019 | 1054 | 0.800 |
Why?
|
Hospitals, Community | 1 | 2023 | 347 | 0.780 |
Why?
|
Nonlinear Dynamics | 5 | 2012 | 503 | 0.780 |
Why?
|
Blood Pressure Determination | 11 | 2023 | 630 | 0.770 |
Why?
|
Dementia | 8 | 2023 | 2488 | 0.760 |
Why?
|
Patient Transfer | 4 | 2021 | 763 | 0.740 |
Why?
|
Vibration | 6 | 2018 | 326 | 0.730 |
Why?
|
Attention | 8 | 2023 | 2400 | 0.720 |
Why?
|
Public Housing | 2 | 2020 | 144 | 0.710 |
Why?
|
Vestibular Diseases | 2 | 2020 | 218 | 0.700 |
Why?
|
Vascular Malformations | 2 | 2015 | 442 | 0.690 |
Why?
|
Prospective Studies | 59 | 2023 | 53037 | 0.660 |
Why?
|
Amlodipine | 1 | 2018 | 79 | 0.650 |
Why?
|
Boston | 28 | 2022 | 9314 | 0.640 |
Why?
|
Metoprolol | 1 | 2018 | 92 | 0.640 |
Why?
|
Ramipril | 1 | 2018 | 95 | 0.640 |
Why?
|
Vasomotor System | 4 | 2006 | 210 | 0.630 |
Why?
|
Cultural Diversity | 1 | 2021 | 357 | 0.630 |
Why?
|
Hemodynamics | 13 | 2020 | 4197 | 0.620 |
Why?
|
Shoes | 3 | 2014 | 97 | 0.620 |
Why?
|
Health Services for the Aged | 4 | 2021 | 268 | 0.610 |
Why?
|
Baroreflex | 6 | 2020 | 147 | 0.600 |
Why?
|
Trail Making Test | 3 | 2018 | 57 | 0.600 |
Why?
|
Adaptation, Physiological | 3 | 2012 | 1310 | 0.590 |
Why?
|
Eating | 13 | 2000 | 1526 | 0.590 |
Why?
|
Benzimidazoles | 2 | 2013 | 849 | 0.590 |
Why?
|
Risk Factors | 73 | 2024 | 71974 | 0.590 |
Why?
|
Task Performance and Analysis | 4 | 2021 | 780 | 0.590 |
Why?
|
Fractals | 5 | 2017 | 123 | 0.590 |
Why?
|
Tetrazoles | 2 | 2013 | 831 | 0.580 |
Why?
|
Renin-Angiotensin System | 3 | 2010 | 763 | 0.580 |
Why?
|
Social Support | 4 | 2021 | 2112 | 0.570 |
Why?
|
Motor Skills | 2 | 2018 | 520 | 0.550 |
Why?
|
Noise | 4 | 2016 | 278 | 0.550 |
Why?
|
Depression | 8 | 2015 | 7689 | 0.550 |
Why?
|
Muscle Contraction | 2 | 2021 | 1240 | 0.540 |
Why?
|
Delirium | 11 | 2019 | 1604 | 0.540 |
Why?
|
Corpus Callosum | 1 | 2020 | 739 | 0.530 |
Why?
|
Insurance, Long-Term Care | 1 | 2015 | 18 | 0.530 |
Why?
|
Chelation Therapy | 1 | 2015 | 67 | 0.530 |
Why?
|
Retinal Diseases | 2 | 2011 | 687 | 0.520 |
Why?
|
Monitoring, Ambulatory | 2 | 2016 | 354 | 0.500 |
Why?
|
Sensory Aids | 1 | 2014 | 44 | 0.500 |
Why?
|
Restraint, Physical | 1 | 2016 | 193 | 0.500 |
Why?
|
Lisinopril | 2 | 2012 | 55 | 0.490 |
Why?
|
Central Nervous System | 4 | 2016 | 1362 | 0.490 |
Why?
|
Resilience, Psychological | 1 | 2021 | 650 | 0.480 |
Why?
|
Interprofessional Relations | 1 | 2020 | 1008 | 0.480 |
Why?
|
Respiration | 9 | 2015 | 1650 | 0.480 |
Why?
|
Hydrochlorothiazide | 2 | 2012 | 99 | 0.470 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15070 | 0.470 |
Why?
|
Patient Readmission | 4 | 2023 | 3106 | 0.470 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2015 | 773 | 0.470 |
Why?
|
Massachusetts | 8 | 2022 | 8669 | 0.460 |
Why?
|
Brain | 19 | 2022 | 26345 | 0.460 |
Why?
|
Renin | 2 | 2014 | 637 | 0.460 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2019 | 1515 | 0.460 |
Why?
|
Longitudinal Studies | 18 | 2023 | 13880 | 0.460 |
Why?
|
Recovery of Function | 4 | 2019 | 2924 | 0.460 |
Why?
|
Muscle Tonus | 1 | 2013 | 81 | 0.450 |
Why?
|
Prefrontal Cortex | 4 | 2021 | 2138 | 0.450 |
Why?
|
Quality of Life | 8 | 2022 | 12640 | 0.440 |
Why?
|
Lower Extremity | 2 | 2021 | 1145 | 0.440 |
Why?
|
Continuity of Patient Care | 2 | 2017 | 1054 | 0.440 |
Why?
|
Particulate Matter | 3 | 2014 | 2511 | 0.440 |
Why?
|
Physical Therapy Modalities | 3 | 2021 | 545 | 0.440 |
Why?
|
Physiological Phenomena | 1 | 2012 | 18 | 0.440 |
Why?
|
Erythropoietin | 2 | 2015 | 724 | 0.440 |
Why?
|
Patient Care Planning | 2 | 2014 | 918 | 0.430 |
Why?
|
Reflex | 3 | 2013 | 359 | 0.430 |
Why?
|
Rehabilitation | 1 | 2013 | 134 | 0.420 |
Why?
|
Acceleration | 2 | 2022 | 181 | 0.420 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2013 | 1539 | 0.420 |
Why?
|
Flavonols | 2 | 2023 | 82 | 0.420 |
Why?
|
Homeostasis | 16 | 2022 | 3348 | 0.420 |
Why?
|
Emergency Service, Hospital | 10 | 2017 | 7626 | 0.420 |
Why?
|
Remote Consultation | 1 | 2014 | 239 | 0.410 |
Why?
|
Nerve Fibers, Myelinated | 4 | 2013 | 964 | 0.410 |
Why?
|
Length of Stay | 7 | 2023 | 6295 | 0.400 |
Why?
|
Prevalence | 20 | 2022 | 15153 | 0.400 |
Why?
|
Middle Aged | 90 | 2024 | 212863 | 0.400 |
Why?
|
Intelligence | 3 | 2011 | 919 | 0.400 |
Why?
|
Vasodilator Agents | 3 | 2009 | 976 | 0.400 |
Why?
|
Models, Cardiovascular | 6 | 2009 | 997 | 0.390 |
Why?
|
Sensation Disorders | 3 | 2009 | 156 | 0.390 |
Why?
|
Disabled Persons | 3 | 2013 | 1207 | 0.390 |
Why?
|
Apolipoprotein E4 | 2 | 2015 | 669 | 0.380 |
Why?
|
Syncope, Vasovagal | 4 | 2011 | 38 | 0.380 |
Why?
|
Reaction Time | 2 | 2015 | 2097 | 0.380 |
Why?
|
Aldosterone | 2 | 2014 | 870 | 0.380 |
Why?
|
Proprioception | 3 | 2003 | 132 | 0.380 |
Why?
|
Age Factors | 29 | 2019 | 18349 | 0.380 |
Why?
|
Residence Characteristics | 6 | 2014 | 2041 | 0.370 |
Why?
|
Analgesics | 4 | 2006 | 1034 | 0.360 |
Why?
|
Cross-Over Studies | 9 | 2018 | 2030 | 0.360 |
Why?
|
Government Regulation | 2 | 2013 | 525 | 0.350 |
Why?
|
Carotid Arteries | 2 | 2005 | 952 | 0.350 |
Why?
|
Neuropsychological Tests | 12 | 2018 | 6963 | 0.350 |
Why?
|
Stochastic Processes | 5 | 2013 | 346 | 0.350 |
Why?
|
Nerve Net | 2 | 2018 | 2179 | 0.340 |
Why?
|
Double-Blind Method | 14 | 2021 | 11985 | 0.340 |
Why?
|
Chronic Disease | 6 | 2019 | 9133 | 0.340 |
Why?
|
Microcirculation | 5 | 2014 | 1285 | 0.340 |
Why?
|
Quality Improvement | 3 | 2021 | 3730 | 0.330 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2009 | 54 | 0.330 |
Why?
|
Pressure Ulcer | 5 | 1999 | 154 | 0.330 |
Why?
|
Analysis of Variance | 17 | 2010 | 6370 | 0.330 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 6 | 2015 | 1510 | 0.330 |
Why?
|
Models, Organizational | 1 | 2012 | 573 | 0.330 |
Why?
|
Risk Assessment | 15 | 2022 | 23294 | 0.330 |
Why?
|
Caregivers | 5 | 2022 | 2067 | 0.330 |
Why?
|
Models, Biological | 6 | 2010 | 9609 | 0.330 |
Why?
|
Parkinson Disease | 6 | 2021 | 2780 | 0.330 |
Why?
|
Enteral Nutrition | 3 | 2000 | 758 | 0.320 |
Why?
|
Orthotic Devices | 1 | 2009 | 128 | 0.320 |
Why?
|
Touch | 3 | 2012 | 306 | 0.320 |
Why?
|
Cross-Sectional Studies | 28 | 2023 | 24714 | 0.320 |
Why?
|
Cohort Studies | 30 | 2018 | 40389 | 0.310 |
Why?
|
Health Personnel | 1 | 2021 | 3203 | 0.310 |
Why?
|
Patient Discharge | 6 | 2023 | 3286 | 0.310 |
Why?
|
Environment | 4 | 2015 | 1110 | 0.310 |
Why?
|
Health Status | 5 | 2017 | 4013 | 0.310 |
Why?
|
Single-Blind Method | 3 | 2017 | 1585 | 0.300 |
Why?
|
Antidepressive Agents | 4 | 2013 | 2836 | 0.300 |
Why?
|
Follow-Up Studies | 21 | 2023 | 38942 | 0.300 |
Why?
|
Sleep | 1 | 2023 | 4596 | 0.300 |
Why?
|
Life Expectancy | 1 | 2014 | 1208 | 0.300 |
Why?
|
Poverty | 1 | 2019 | 2626 | 0.300 |
Why?
|
Adiponectin | 1 | 2013 | 1096 | 0.300 |
Why?
|
Sensory Thresholds | 4 | 2018 | 395 | 0.290 |
Why?
|
Disease Susceptibility | 3 | 2015 | 1778 | 0.290 |
Why?
|
Health | 2 | 2017 | 390 | 0.290 |
Why?
|
Dizziness | 4 | 2023 | 251 | 0.290 |
Why?
|
Mortality | 2 | 2018 | 2851 | 0.290 |
Why?
|
Autonomic Nervous System Diseases | 3 | 2009 | 256 | 0.280 |
Why?
|
Educational Status | 3 | 2012 | 2514 | 0.280 |
Why?
|
Pain | 5 | 2008 | 4923 | 0.280 |
Why?
|
Isosorbide Dinitrate | 2 | 1996 | 34 | 0.270 |
Why?
|
Health Transition | 1 | 2005 | 34 | 0.270 |
Why?
|
Maine | 3 | 2016 | 139 | 0.270 |
Why?
|
Pilot Projects | 11 | 2021 | 8275 | 0.270 |
Why?
|
Nicardipine | 2 | 1996 | 59 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2017 | 5272 | 0.270 |
Why?
|
Antipsychotic Agents | 2 | 2016 | 3055 | 0.270 |
Why?
|
Retinal Vessels | 1 | 2011 | 774 | 0.260 |
Why?
|
Electrocardiography | 13 | 2014 | 6426 | 0.260 |
Why?
|
Medicare | 6 | 2023 | 6497 | 0.260 |
Why?
|
Carotid Artery Diseases | 1 | 2011 | 879 | 0.260 |
Why?
|
Sex Characteristics | 4 | 2013 | 2583 | 0.260 |
Why?
|
Time Factors | 22 | 2019 | 40050 | 0.250 |
Why?
|
Forecasting | 1 | 2014 | 2952 | 0.250 |
Why?
|
Systems Biology | 1 | 2008 | 471 | 0.250 |
Why?
|
Magnetic Resonance Imaging | 13 | 2021 | 35326 | 0.240 |
Why?
|
Artifacts | 1 | 2013 | 1905 | 0.240 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 3 | 2015 | 454 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 9812 | 0.240 |
Why?
|
Mathematics | 4 | 2010 | 728 | 0.240 |
Why?
|
Supine Position | 5 | 2006 | 210 | 0.240 |
Why?
|
Mental Health | 2 | 2017 | 2946 | 0.240 |
Why?
|
Motivation | 2 | 2011 | 1965 | 0.240 |
Why?
|
Frontal Lobe | 3 | 2011 | 1409 | 0.240 |
Why?
|
Mood Disorders | 1 | 2011 | 1102 | 0.240 |
Why?
|
United States | 30 | 2023 | 69573 | 0.240 |
Why?
|
Carbon Dioxide | 5 | 2015 | 1142 | 0.230 |
Why?
|
Regression Analysis | 13 | 2010 | 6452 | 0.230 |
Why?
|
Ferrets | 2 | 2001 | 194 | 0.230 |
Why?
|
Comorbidity | 13 | 2018 | 10362 | 0.230 |
Why?
|
Adult | 67 | 2023 | 213394 | 0.230 |
Why?
|
Vision Disorders | 1 | 2010 | 1058 | 0.230 |
Why?
|
Family | 3 | 2018 | 3141 | 0.220 |
Why?
|
Nervous System Physiological Phenomena | 2 | 2002 | 116 | 0.220 |
Why?
|
Accidents, Home | 3 | 2015 | 75 | 0.220 |
Why?
|
Quercetin | 1 | 2023 | 93 | 0.220 |
Why?
|
Stress, Physiological | 2 | 2008 | 1405 | 0.220 |
Why?
|
Air Pollution | 2 | 2014 | 2268 | 0.210 |
Why?
|
Checklist | 2 | 2020 | 817 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2015 | 10945 | 0.210 |
Why?
|
Polymorphism, Genetic | 2 | 2010 | 4332 | 0.210 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 940 | 0.210 |
Why?
|
Homocysteine | 1 | 2005 | 647 | 0.210 |
Why?
|
Insurance Coverage | 1 | 2013 | 1891 | 0.210 |
Why?
|
Estrogen Replacement Therapy | 2 | 2001 | 1203 | 0.210 |
Why?
|
Somatosensory Cortex | 3 | 2018 | 527 | 0.210 |
Why?
|
Fever | 2 | 2000 | 1607 | 0.210 |
Why?
|
Stroke | 10 | 2024 | 9898 | 0.200 |
Why?
|
Hospitalization | 13 | 2015 | 10208 | 0.200 |
Why?
|
Logistic Models | 15 | 2014 | 13402 | 0.200 |
Why?
|
Fludrocortisone | 2 | 2013 | 25 | 0.200 |
Why?
|
Midodrine | 2 | 2013 | 22 | 0.200 |
Why?
|
Clinical Audit | 1 | 2020 | 31 | 0.190 |
Why?
|
Hospitals, Teaching | 3 | 2023 | 1166 | 0.190 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 2 | 2011 | 53 | 0.190 |
Why?
|
Head-Down Tilt | 2 | 1997 | 64 | 0.190 |
Why?
|
Movement | 4 | 2008 | 1481 | 0.190 |
Why?
|
Leukoencephalopathies | 2 | 2013 | 237 | 0.180 |
Why?
|
Systole | 6 | 2007 | 956 | 0.180 |
Why?
|
Anisotropy | 3 | 2020 | 1265 | 0.180 |
Why?
|
Sex Factors | 12 | 2019 | 10398 | 0.180 |
Why?
|
Hip Joint | 3 | 2010 | 1000 | 0.180 |
Why?
|
Diuretics | 4 | 2015 | 590 | 0.180 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2000 | 179 | 0.180 |
Why?
|
Education, Continuing | 1 | 2020 | 112 | 0.180 |
Why?
|
Incidence | 12 | 2019 | 20913 | 0.180 |
Why?
|
Models, Statistical | 6 | 2017 | 5113 | 0.180 |
Why?
|
Leg | 3 | 2013 | 1107 | 0.180 |
Why?
|
Reproducibility of Results | 11 | 2022 | 19811 | 0.180 |
Why?
|
Ankle Brachial Index | 2 | 2023 | 154 | 0.170 |
Why?
|
Essential Tremor | 1 | 2021 | 131 | 0.170 |
Why?
|
Diet, Sodium-Restricted | 1 | 2021 | 287 | 0.170 |
Why?
|
Vision, Ocular | 5 | 2016 | 471 | 0.170 |
Why?
|
Arrhythmia, Sinus | 1 | 1998 | 56 | 0.170 |
Why?
|
Survival Analysis | 8 | 2018 | 10247 | 0.170 |
Why?
|
Decision Making | 5 | 2018 | 3854 | 0.170 |
Why?
|
Posterior Cerebral Artery | 2 | 2009 | 26 | 0.160 |
Why?
|
Information Dissemination | 2 | 2018 | 1106 | 0.160 |
Why?
|
Feedback, Physiological | 3 | 2010 | 478 | 0.160 |
Why?
|
Treatment Outcome | 15 | 2019 | 62693 | 0.160 |
Why?
|
Internet | 4 | 2018 | 3048 | 0.160 |
Why?
|
Social Isolation | 1 | 2021 | 361 | 0.160 |
Why?
|
Patient Selection | 5 | 2017 | 4211 | 0.160 |
Why?
|
Functional Laterality | 3 | 2013 | 2291 | 0.160 |
Why?
|
Reference Values | 9 | 2009 | 4983 | 0.160 |
Why?
|
Parkinsonian Disorders | 1 | 2021 | 274 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2010 | 364 | 0.160 |
Why?
|
Climate Change | 1 | 2023 | 411 | 0.160 |
Why?
|
Respiratory Mechanics | 1 | 2002 | 681 | 0.160 |
Why?
|
Postprandial Period | 1 | 1999 | 293 | 0.160 |
Why?
|
Mastication | 1 | 1998 | 53 | 0.160 |
Why?
|
Cardiovascular System | 3 | 2023 | 830 | 0.160 |
Why?
|
Biphenyl Compounds | 2 | 2013 | 909 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 1999 | 162 | 0.160 |
Why?
|
Physical Stimulation | 3 | 2012 | 526 | 0.160 |
Why?
|
Population Surveillance | 1 | 2008 | 2629 | 0.150 |
Why?
|
Hot Temperature | 1 | 2023 | 1358 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2022 | 375 | 0.150 |
Why?
|
Sensation | 3 | 2013 | 332 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 250 | 0.150 |
Why?
|
Reminder Systems | 2 | 2011 | 370 | 0.150 |
Why?
|
Practice Guidelines as Topic | 8 | 2021 | 7274 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2015 | 1238 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2023 | 3401 | 0.150 |
Why?
|
Morbidity | 3 | 2013 | 1763 | 0.150 |
Why?
|
Pressoreceptors | 4 | 1992 | 101 | 0.150 |
Why?
|
Multivariate Analysis | 12 | 2010 | 12237 | 0.150 |
Why?
|
Droxidopa | 1 | 1996 | 10 | 0.150 |
Why?
|
Coronary Disease | 5 | 2023 | 6068 | 0.150 |
Why?
|
Self Efficacy | 2 | 2020 | 607 | 0.150 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4454 | 0.150 |
Why?
|
Thiadiazoles | 1 | 1997 | 55 | 0.150 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 1999 | 303 | 0.150 |
Why?
|
Bacteriuria | 2 | 1995 | 100 | 0.150 |
Why?
|
Amino Acids | 2 | 2000 | 1727 | 0.150 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5721 | 0.150 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2202 | 0.140 |
Why?
|
Muscarinic Agonists | 1 | 1997 | 87 | 0.140 |
Why?
|
Diffusion Tensor Imaging | 3 | 2018 | 2301 | 0.140 |
Why?
|
Caffeine | 2 | 2007 | 697 | 0.140 |
Why?
|
Osteoporosis | 4 | 2021 | 1576 | 0.140 |
Why?
|
Supination | 4 | 1991 | 68 | 0.140 |
Why?
|
Tilt-Table Test | 3 | 2009 | 81 | 0.140 |
Why?
|
Medication Errors | 2 | 2020 | 797 | 0.140 |
Why?
|
Digestive System Diseases | 1 | 1998 | 146 | 0.140 |
Why?
|
Antiparkinson Agents | 1 | 1997 | 183 | 0.140 |
Why?
|
Receptors, Muscarinic | 1 | 1997 | 156 | 0.140 |
Why?
|
Prognosis | 10 | 2018 | 28901 | 0.140 |
Why?
|
Vasodilation | 3 | 2009 | 947 | 0.140 |
Why?
|
Touch Perception | 1 | 2018 | 115 | 0.140 |
Why?
|
Information Seeking Behavior | 1 | 2017 | 112 | 0.140 |
Why?
|
Institutionalization | 5 | 1994 | 104 | 0.140 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2015 | 6028 | 0.140 |
Why?
|
Solubility | 1 | 2018 | 1083 | 0.140 |
Why?
|
Food | 2 | 1995 | 760 | 0.140 |
Why?
|
Interpersonal Relations | 3 | 2017 | 1421 | 0.140 |
Why?
|
Homebound Persons | 1 | 1996 | 49 | 0.140 |
Why?
|
Drug Monitoring | 2 | 2021 | 961 | 0.140 |
Why?
|
Disease | 1 | 2002 | 683 | 0.140 |
Why?
|
Accidents | 3 | 1990 | 164 | 0.140 |
Why?
|
Cerebral Arteries | 2 | 2002 | 492 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2019 | 969 | 0.130 |
Why?
|
Diabetic Neuropathies | 3 | 2006 | 410 | 0.130 |
Why?
|
Feedback | 3 | 2009 | 788 | 0.130 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3510 | 0.130 |
Why?
|
Financing, Government | 1 | 2019 | 470 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2015 | 5702 | 0.130 |
Why?
|
Nursing Assessment | 1 | 1995 | 107 | 0.130 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 477 | 0.130 |
Why?
|
Neurotransmitter Agents | 1 | 1999 | 646 | 0.130 |
Why?
|
Eye Diseases | 1 | 2001 | 670 | 0.130 |
Why?
|
Pyuria | 2 | 1995 | 30 | 0.130 |
Why?
|
Proportional Hazards Models | 8 | 2011 | 12328 | 0.130 |
Why?
|
Encephalitis | 1 | 2019 | 423 | 0.130 |
Why?
|
Reimbursement, Incentive | 1 | 2020 | 537 | 0.130 |
Why?
|
Chick Embryo | 1 | 1997 | 978 | 0.130 |
Why?
|
Aspirin | 2 | 2009 | 3268 | 0.130 |
Why?
|
Research Design | 3 | 2018 | 5959 | 0.130 |
Why?
|
Food Analysis | 1 | 1995 | 104 | 0.130 |
Why?
|
Nursing Staff | 1 | 2016 | 129 | 0.130 |
Why?
|
Polychlorinated Biphenyls | 1 | 1997 | 245 | 0.130 |
Why?
|
Muscles | 4 | 1994 | 1608 | 0.130 |
Why?
|
Personnel Selection | 1 | 1996 | 189 | 0.120 |
Why?
|
Mental Disorders | 1 | 2014 | 6570 | 0.120 |
Why?
|
Cerebral Infarction | 2 | 2010 | 1004 | 0.120 |
Why?
|
Drug Prescriptions | 1 | 2004 | 1637 | 0.120 |
Why?
|
Altitude | 1 | 1995 | 160 | 0.120 |
Why?
|
Feedback, Sensory | 1 | 2014 | 55 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 685 | 0.120 |
Why?
|
Visual Perception | 4 | 2010 | 1418 | 0.120 |
Why?
|
Subacute Care | 1 | 2016 | 168 | 0.120 |
Why?
|
Cholesterol | 3 | 2012 | 2900 | 0.120 |
Why?
|
Predictive Value of Tests | 9 | 2019 | 15036 | 0.120 |
Why?
|
Pneumonia | 2 | 1997 | 2102 | 0.120 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1997 | 320 | 0.120 |
Why?
|
Health Records, Personal | 1 | 2015 | 124 | 0.120 |
Why?
|
Linear Models | 8 | 2009 | 5948 | 0.120 |
Why?
|
Football | 1 | 2019 | 453 | 0.120 |
Why?
|
Retrospective Studies | 21 | 2021 | 76631 | 0.120 |
Why?
|
Telemetry | 2 | 2010 | 204 | 0.120 |
Why?
|
Electromyography | 3 | 2017 | 1389 | 0.120 |
Why?
|
Ultrasonography, Doppler | 2 | 2013 | 460 | 0.120 |
Why?
|
Motor Cortex | 1 | 2021 | 984 | 0.120 |
Why?
|
RNA, Viral | 1 | 2022 | 2907 | 0.120 |
Why?
|
Family Health | 1 | 2019 | 1281 | 0.120 |
Why?
|
Neural Pathways | 3 | 2021 | 2976 | 0.120 |
Why?
|
Visual Cortex | 3 | 2009 | 1155 | 0.120 |
Why?
|
Medication Adherence | 2 | 2019 | 2047 | 0.110 |
Why?
|
Creatine Kinase | 2 | 2003 | 694 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2019 | 11699 | 0.110 |
Why?
|
Preventive Medicine | 1 | 1995 | 263 | 0.110 |
Why?
|
Pulmonary Gas Exchange | 1 | 2015 | 381 | 0.110 |
Why?
|
Oscillometry | 1 | 2013 | 147 | 0.110 |
Why?
|
Calcium Channel Blockers | 2 | 2015 | 686 | 0.110 |
Why?
|
Memory | 4 | 2006 | 2161 | 0.110 |
Why?
|
Angiotensinogen | 2 | 2010 | 163 | 0.110 |
Why?
|
Tidal Volume | 1 | 2015 | 490 | 0.110 |
Why?
|
Thinking | 2 | 2010 | 320 | 0.110 |
Why?
|
Normal Distribution | 1 | 2013 | 282 | 0.110 |
Why?
|
Haloperidol | 1 | 2014 | 397 | 0.110 |
Why?
|
Pandemics | 2 | 2023 | 8274 | 0.110 |
Why?
|
Confidence Intervals | 6 | 2017 | 2974 | 0.110 |
Why?
|
Psychomotor Agitation | 1 | 2014 | 287 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1192 | 0.110 |
Why?
|
Deglutition Disorders | 1 | 1998 | 607 | 0.110 |
Why?
|
Interview, Psychological | 1 | 1995 | 812 | 0.100 |
Why?
|
Health Care Surveys | 2 | 1999 | 2448 | 0.100 |
Why?
|
Vagus Nerve | 3 | 2001 | 432 | 0.100 |
Why?
|
Data Interpretation, Statistical | 3 | 2013 | 2716 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2019 | 2711 | 0.100 |
Why?
|
Social Control, Formal | 1 | 2012 | 109 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 757 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 4 | 1995 | 235 | 0.100 |
Why?
|
Health Care Costs | 2 | 2017 | 3226 | 0.100 |
Why?
|
User-Computer Interface | 1 | 2018 | 1423 | 0.100 |
Why?
|
Medical Staff, Hospital | 1 | 2016 | 601 | 0.100 |
Why?
|
Acoustic Stimulation | 1 | 2016 | 1216 | 0.100 |
Why?
|
Animals, Newborn | 1 | 1997 | 2732 | 0.100 |
Why?
|
Orthostatic Intolerance | 1 | 2011 | 21 | 0.100 |
Why?
|
Muscle, Skeletal | 3 | 2021 | 4920 | 0.100 |
Why?
|
Odds Ratio | 9 | 2014 | 9846 | 0.100 |
Why?
|
Exercise | 5 | 2020 | 5591 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2002 | 2146 | 0.100 |
Why?
|
Medical Informatics | 1 | 2018 | 740 | 0.100 |
Why?
|
Affect | 3 | 2006 | 1475 | 0.100 |
Why?
|
Decision Support Techniques | 3 | 2014 | 1957 | 0.100 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2013 | 703 | 0.100 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1416 | 0.100 |
Why?
|
Case-Control Studies | 7 | 2018 | 21694 | 0.100 |
Why?
|
Postmenopause | 2 | 2001 | 2456 | 0.100 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 135 | 0.100 |
Why?
|
Heart Failure | 7 | 2008 | 10793 | 0.100 |
Why?
|
Cross-Cultural Comparison | 1 | 1994 | 648 | 0.100 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 247 | 0.100 |
Why?
|
Angina Pectoris | 1 | 1995 | 976 | 0.090 |
Why?
|
Plethysmography | 1 | 1991 | 180 | 0.090 |
Why?
|
Appointments and Schedules | 2 | 2011 | 415 | 0.090 |
Why?
|
Memory, Short-Term | 3 | 2018 | 974 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2003 | 3382 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 6516 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2011 | 3743 | 0.090 |
Why?
|
Myocardium | 1 | 2003 | 4788 | 0.090 |
Why?
|
Sympathetic Nervous System | 3 | 1999 | 514 | 0.090 |
Why?
|
Air Pollutants | 2 | 2014 | 2801 | 0.090 |
Why?
|
Guideline Adherence | 3 | 2017 | 2261 | 0.090 |
Why?
|
Pulmonary Ventilation | 1 | 2012 | 373 | 0.090 |
Why?
|
Systems Analysis | 2 | 2022 | 170 | 0.090 |
Why?
|
Receptors, Angiotensin | 1 | 2010 | 142 | 0.090 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2394 | 0.090 |
Why?
|
Otolithic Membrane | 1 | 2009 | 41 | 0.090 |
Why?
|
Morphine | 1 | 2014 | 655 | 0.090 |
Why?
|
Entropy | 3 | 2016 | 210 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2014 | 4220 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 1996 | 845 | 0.090 |
Why?
|
Program Evaluation | 2 | 2016 | 2484 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 4935 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2015 | 1099 | 0.090 |
Why?
|
Hearing | 1 | 2013 | 478 | 0.090 |
Why?
|
Uremia | 1 | 1990 | 200 | 0.090 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2011 | 247 | 0.090 |
Why?
|
Choice Behavior | 1 | 2015 | 801 | 0.090 |
Why?
|
Cardiac Volume | 1 | 1990 | 210 | 0.090 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1158 | 0.090 |
Why?
|
Urban Population | 1 | 2017 | 2014 | 0.080 |
Why?
|
Cerebrovascular Disorders | 4 | 2010 | 1497 | 0.080 |
Why?
|
Withholding Treatment | 1 | 2013 | 596 | 0.080 |
Why?
|
Body Mass Index | 6 | 2019 | 12655 | 0.080 |
Why?
|
Digoxin | 2 | 2000 | 251 | 0.080 |
Why?
|
Databases as Topic | 3 | 1999 | 473 | 0.080 |
Why?
|
Diastole | 3 | 1998 | 791 | 0.080 |
Why?
|
Algorithms | 3 | 2013 | 13872 | 0.080 |
Why?
|
Communication | 3 | 2018 | 3722 | 0.080 |
Why?
|
Norepinephrine | 3 | 1999 | 910 | 0.080 |
Why?
|
Beverages | 1 | 1994 | 817 | 0.080 |
Why?
|
Fruit | 1 | 1994 | 1139 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 554 | 0.080 |
Why?
|
Health Promotion | 3 | 2021 | 2187 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 881 | 0.080 |
Why?
|
Home Care Services | 1 | 2014 | 602 | 0.080 |
Why?
|
Aortic Valve Stenosis | 2 | 2019 | 1930 | 0.080 |
Why?
|
Prostaglandin Antagonists | 1 | 2007 | 30 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1313 | 0.080 |
Why?
|
Research | 1 | 1996 | 2001 | 0.080 |
Why?
|
Ankle Joint | 2 | 2010 | 409 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 2 | 2016 | 3517 | 0.080 |
Why?
|
Mental Recall | 2 | 2010 | 1201 | 0.080 |
Why?
|
Health Surveys | 4 | 2019 | 4022 | 0.080 |
Why?
|
Postoperative Complications | 5 | 2023 | 15194 | 0.080 |
Why?
|
Anterior Cerebral Artery | 1 | 2007 | 48 | 0.080 |
Why?
|
Ligation | 1 | 2008 | 453 | 0.080 |
Why?
|
Psychological Tests | 2 | 2010 | 649 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2004 | 2277 | 0.080 |
Why?
|
Signal Transduction | 2 | 2015 | 23355 | 0.080 |
Why?
|
Musculoskeletal System | 1 | 2009 | 175 | 0.080 |
Why?
|
Socioeconomic Factors | 3 | 2013 | 7726 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2010 | 937 | 0.080 |
Why?
|
Thigh | 1 | 2008 | 249 | 0.070 |
Why?
|
Intelligence Tests | 1 | 2008 | 505 | 0.070 |
Why?
|
Syndrome | 2 | 2004 | 3241 | 0.070 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2007 | 177 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3916 | 0.070 |
Why?
|
Brain Ischemia | 3 | 2013 | 3246 | 0.070 |
Why?
|
Young Adult | 7 | 2015 | 56255 | 0.070 |
Why?
|
Employment | 1 | 2013 | 1119 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1177 | 0.070 |
Why?
|
Drug Utilization | 3 | 2004 | 1181 | 0.070 |
Why?
|
Clinical Protocols | 2 | 2009 | 1453 | 0.070 |
Why?
|
Sex Distribution | 2 | 2005 | 2296 | 0.070 |
Why?
|
Leptin | 1 | 2014 | 1589 | 0.070 |
Why?
|
Fingers | 3 | 2006 | 511 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2013 | 15511 | 0.070 |
Why?
|
Advance Directives | 2 | 2000 | 245 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 601 | 0.070 |
Why?
|
Nerve Degeneration | 2 | 2008 | 759 | 0.070 |
Why?
|
Brain Mapping | 3 | 2021 | 6666 | 0.070 |
Why?
|
Longevity | 1 | 1993 | 1066 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2000 | 1580 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 474 | 0.070 |
Why?
|
Ukraine | 1 | 2005 | 110 | 0.070 |
Why?
|
Exercise Test | 2 | 2007 | 2069 | 0.070 |
Why?
|
Risk | 4 | 2011 | 9684 | 0.070 |
Why?
|
Arthralgia | 1 | 2009 | 457 | 0.070 |
Why?
|
Medicine, Traditional | 1 | 2005 | 90 | 0.070 |
Why?
|
Patient Care Team | 1 | 2016 | 2527 | 0.070 |
Why?
|
Interviews as Topic | 2 | 2012 | 2533 | 0.060 |
Why?
|
Research Subjects | 1 | 1987 | 237 | 0.060 |
Why?
|
Compliance | 1 | 2005 | 105 | 0.060 |
Why?
|
Pyridines | 1 | 1997 | 2810 | 0.060 |
Why?
|
Social Change | 1 | 2005 | 152 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2005 | 124 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8977 | 0.060 |
Why?
|
Knee Joint | 3 | 2010 | 1676 | 0.060 |
Why?
|
Models, Neurological | 2 | 2004 | 1769 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 799 | 0.060 |
Why?
|
Photoplethysmography | 1 | 2005 | 58 | 0.060 |
Why?
|
Splanchnic Circulation | 2 | 1995 | 110 | 0.060 |
Why?
|
Patient Admission | 2 | 2011 | 1383 | 0.060 |
Why?
|
Hip Fractures | 1 | 1993 | 953 | 0.060 |
Why?
|
Phenotype | 3 | 2019 | 16301 | 0.060 |
Why?
|
Nifedipine | 1 | 2005 | 227 | 0.060 |
Why?
|
Alzheimer Disease | 5 | 2008 | 7975 | 0.060 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2009 | 584 | 0.060 |
Why?
|
Blood Circulation | 1 | 2005 | 253 | 0.060 |
Why?
|
Insurance Claim Review | 2 | 2019 | 720 | 0.060 |
Why?
|
Genotype | 4 | 2015 | 12951 | 0.060 |
Why?
|
Atrophy | 1 | 2008 | 1571 | 0.060 |
Why?
|
Aortic Valve | 1 | 2014 | 1900 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2500 | 0.060 |
Why?
|
Administration, Oral | 3 | 2014 | 3909 | 0.060 |
Why?
|
Narcotics | 1 | 2006 | 343 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 1996 | 3620 | 0.060 |
Why?
|
Ticlopidine | 1 | 2009 | 899 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2749 | 0.060 |
Why?
|
Muscle Relaxation | 1 | 2003 | 142 | 0.060 |
Why?
|
Obesity | 1 | 2006 | 12643 | 0.060 |
Why?
|
Mental Status Schedule | 2 | 2014 | 321 | 0.060 |
Why?
|
Hospitals, Urban | 2 | 2015 | 503 | 0.060 |
Why?
|
Anthocyanins | 1 | 2023 | 75 | 0.060 |
Why?
|
Health Care Reform | 1 | 2012 | 1258 | 0.050 |
Why?
|
Problem Solving | 1 | 2005 | 438 | 0.050 |
Why?
|
Physical Fitness | 2 | 2019 | 733 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2913 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 2 | 2013 | 1777 | 0.050 |
Why?
|
Orientation | 2 | 1994 | 327 | 0.050 |
Why?
|
Echocardiography, Doppler | 2 | 1996 | 934 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2003 | 183 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 1994 | 2275 | 0.050 |
Why?
|
Internal Medicine | 2 | 1996 | 996 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 1983 | 163 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2001 | 18003 | 0.050 |
Why?
|
Biological Clocks | 1 | 2004 | 322 | 0.050 |
Why?
|
Canada | 2 | 2019 | 2021 | 0.050 |
Why?
|
Focus Groups | 2 | 2017 | 1308 | 0.050 |
Why?
|
Hemostasis | 1 | 2004 | 459 | 0.050 |
Why?
|
Spain | 1 | 2023 | 463 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2517 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2013 | 1776 | 0.050 |
Why?
|
Unconsciousness | 1 | 2003 | 261 | 0.050 |
Why?
|
Breeding | 1 | 2001 | 52 | 0.050 |
Why?
|
Hypesthesia | 1 | 2002 | 110 | 0.050 |
Why?
|
Heart | 2 | 1997 | 4466 | 0.050 |
Why?
|
Recurrence | 5 | 2012 | 8307 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2006 | 11668 | 0.050 |
Why?
|
Heart Diseases | 3 | 2011 | 2782 | 0.050 |
Why?
|
Southeastern United States | 1 | 2001 | 94 | 0.050 |
Why?
|
Elasticity | 1 | 2003 | 656 | 0.050 |
Why?
|
Peroneal Nerve | 1 | 2001 | 78 | 0.050 |
Why?
|
Minority Groups | 2 | 1999 | 1197 | 0.050 |
Why?
|
Electricity | 1 | 2002 | 182 | 0.050 |
Why?
|
Motor Activity | 2 | 2009 | 2719 | 0.050 |
Why?
|
Nitroprusside | 1 | 2001 | 275 | 0.050 |
Why?
|
Lung Volume Measurements | 1 | 2002 | 377 | 0.050 |
Why?
|
Primary Health Care | 2 | 2011 | 4537 | 0.050 |
Why?
|
Dementia, Vascular | 1 | 2002 | 127 | 0.050 |
Why?
|
Mass Screening | 3 | 2011 | 5265 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3506 | 0.050 |
Why?
|
Age Distribution | 2 | 1997 | 2904 | 0.050 |
Why?
|
Electric Stimulation | 2 | 2003 | 1769 | 0.050 |
Why?
|
Demography | 1 | 2005 | 1650 | 0.050 |
Why?
|
Risk Reduction Behavior | 1 | 2007 | 1123 | 0.050 |
Why?
|
Warfarin | 1 | 2009 | 1484 | 0.050 |
Why?
|
Statistics as Topic | 2 | 2010 | 2373 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2275 | 0.050 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2002 | 161 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1995 | 3908 | 0.050 |
Why?
|
Phosphites | 1 | 1999 | 3 | 0.050 |
Why?
|
Self Care | 1 | 2005 | 787 | 0.050 |
Why?
|
Qualitative Research | 2 | 2020 | 2656 | 0.050 |
Why?
|
Biology | 1 | 2022 | 292 | 0.050 |
Why?
|
Environment Design | 1 | 2021 | 177 | 0.050 |
Why?
|
Flavonoids | 1 | 2023 | 443 | 0.040 |
Why?
|
Health Policy | 1 | 2012 | 2655 | 0.040 |
Why?
|
Darkness | 1 | 1999 | 167 | 0.040 |
Why?
|
Preoperative Care | 1 | 2008 | 2238 | 0.040 |
Why?
|
Endorphins | 1 | 1999 | 75 | 0.040 |
Why?
|
Quinuclidinyl Benzilate | 1 | 1999 | 19 | 0.040 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 1676 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 1996 | 1437 | 0.040 |
Why?
|
Troponin I | 1 | 2003 | 616 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2000 | 380 | 0.040 |
Why?
|
Ontario | 1 | 2000 | 375 | 0.040 |
Why?
|
Endothelins | 1 | 1999 | 138 | 0.040 |
Why?
|
Social Behavior | 1 | 2006 | 1131 | 0.040 |
Why?
|
Embryonic Stem Cells | 1 | 2006 | 1294 | 0.040 |
Why?
|
Central Nervous System Stimulants | 1 | 2007 | 1146 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20055 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 90 | 0.040 |
Why?
|
Parasympathetic Nervous System | 1 | 1999 | 141 | 0.040 |
Why?
|
Atropine | 1 | 1999 | 244 | 0.040 |
Why?
|
Phenylalanine | 1 | 2000 | 365 | 0.040 |
Why?
|
Radioimmunoassay | 1 | 1999 | 918 | 0.040 |
Why?
|
Acute Disease | 3 | 1999 | 7128 | 0.040 |
Why?
|
Tritium | 1 | 1999 | 755 | 0.040 |
Why?
|
Geniculate Bodies | 1 | 1999 | 165 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3524 | 0.040 |
Why?
|
Dental Care | 1 | 1981 | 258 | 0.040 |
Why?
|
Muscarinic Antagonists | 1 | 1999 | 136 | 0.040 |
Why?
|
Retirement | 1 | 2019 | 212 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 477 | 0.040 |
Why?
|
Heart Conduction System | 2 | 2009 | 1049 | 0.040 |
Why?
|
Ganglionectomy | 1 | 1997 | 12 | 0.040 |
Why?
|
Wound Healing | 1 | 1989 | 2768 | 0.040 |
Why?
|
France | 1 | 2019 | 516 | 0.040 |
Why?
|
Stellate Ganglion | 1 | 1997 | 44 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2021 | 932 | 0.040 |
Why?
|
Washington | 1 | 1998 | 314 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1456 | 0.040 |
Why?
|
Cause of Death | 2 | 2019 | 3564 | 0.040 |
Why?
|
Sodium, Dietary | 1 | 2021 | 416 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 1998 | 154 | 0.040 |
Why?
|
Acetylcholine | 1 | 1999 | 622 | 0.040 |
Why?
|
Anti-Anxiety Agents | 1 | 1999 | 390 | 0.040 |
Why?
|
Progesterone | 1 | 2001 | 772 | 0.040 |
Why?
|
Confusion | 1 | 1999 | 271 | 0.040 |
Why?
|
Carotid Sinus | 2 | 1986 | 45 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2000 | 535 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2006 | 2272 | 0.040 |
Why?
|
Community Health Services | 1 | 1982 | 652 | 0.040 |
Why?
|
Methods | 1 | 1997 | 1132 | 0.040 |
Why?
|
Pain Measurement | 2 | 2004 | 3419 | 0.040 |
Why?
|
Netherlands | 1 | 2021 | 2169 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 438 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 2270 | 0.030 |
Why?
|
Life Tables | 1 | 1996 | 370 | 0.030 |
Why?
|
Adolescent | 6 | 2015 | 85405 | 0.030 |
Why?
|
Animals | 8 | 2006 | 168368 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6237 | 0.030 |
Why?
|
Digestion | 1 | 1995 | 54 | 0.030 |
Why?
|
Influenza Vaccines | 2 | 2011 | 740 | 0.030 |
Why?
|
Computer Simulation | 2 | 2004 | 6237 | 0.030 |
Why?
|
Hand | 1 | 2021 | 875 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10534 | 0.030 |
Why?
|
Fees and Charges | 1 | 1996 | 195 | 0.030 |
Why?
|
Classification | 1 | 2015 | 128 | 0.030 |
Why?
|
Travel | 1 | 2021 | 787 | 0.030 |
Why?
|
Exercise Therapy | 2 | 1994 | 897 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2016 | 151 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 1995 | 156 | 0.030 |
Why?
|
Pharmacoepidemiology | 1 | 1998 | 322 | 0.030 |
Why?
|
Drug Therapy, Combination | 3 | 2000 | 6478 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2011 | 4426 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 858 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 8960 | 0.030 |
Why?
|
Vertigo | 1 | 1996 | 200 | 0.030 |
Why?
|
Serotonin | 1 | 1999 | 1022 | 0.030 |
Why?
|
Decision Trees | 1 | 1996 | 507 | 0.030 |
Why?
|
Societies, Medical | 2 | 2016 | 3739 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1583 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2018 | 252 | 0.030 |
Why?
|
Internationality | 1 | 2000 | 1004 | 0.030 |
Why?
|
Estrogens | 1 | 2001 | 1561 | 0.030 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2013 | 19 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2001 | 1576 | 0.030 |
Why?
|
Rectal Diseases | 1 | 1995 | 142 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3609 | 0.030 |
Why?
|
Recreation | 1 | 2014 | 115 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4582 | 0.030 |
Why?
|
Metabolic Diseases | 2 | 1999 | 658 | 0.030 |
Why?
|
Perceptual Masking | 2 | 2006 | 94 | 0.030 |
Why?
|
Education, Medical | 1 | 2005 | 1712 | 0.030 |
Why?
|
Finland | 1 | 2014 | 604 | 0.030 |
Why?
|
Consciousness | 1 | 1999 | 569 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6998 | 0.030 |
Why?
|
Family Relations | 1 | 2015 | 322 | 0.030 |
Why?
|
Food, Fortified | 1 | 1994 | 187 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12948 | 0.030 |
Why?
|
Telemedicine | 1 | 2010 | 2844 | 0.030 |
Why?
|
Diffusion | 1 | 1995 | 832 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 546 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 1997 | 522 | 0.030 |
Why?
|
Food, Formulated | 1 | 1993 | 109 | 0.030 |
Why?
|
Patient Participation | 2 | 1995 | 1441 | 0.030 |
Why?
|
Sampling Studies | 1 | 1993 | 624 | 0.030 |
Why?
|
Endocrine Glands | 1 | 1992 | 102 | 0.030 |
Why?
|
Medical Records | 1 | 2017 | 1413 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5213 | 0.030 |
Why?
|
Drinking | 1 | 1993 | 197 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6318 | 0.030 |
Why?
|
Cardiac Output | 1 | 1994 | 857 | 0.030 |
Why?
|
Urinalysis | 1 | 1994 | 370 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 1993 | 332 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1421 | 0.030 |
Why?
|
Autopsy | 1 | 1995 | 1004 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2016 | 760 | 0.020 |
Why?
|
Fecal Incontinence | 1 | 1994 | 239 | 0.020 |
Why?
|
Hydrocortisone | 1 | 1999 | 1809 | 0.020 |
Why?
|
Vaccination | 2 | 2011 | 3232 | 0.020 |
Why?
|
Medical History Taking | 2 | 1986 | 782 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5058 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2417 | 0.020 |
Why?
|
Hormones | 1 | 1995 | 880 | 0.020 |
Why?
|
Nutritional Status | 2 | 2016 | 1587 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 952 | 0.020 |
Why?
|
Carbon | 1 | 2014 | 684 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2589 | 0.020 |
Why?
|
Stress, Psychological | 1 | 1986 | 4212 | 0.020 |
Why?
|
Coma | 1 | 1994 | 471 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 1990 | 188 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 1999 | 1066 | 0.020 |
Why?
|
Apoptosis | 1 | 2006 | 9714 | 0.020 |
Why?
|
Japan | 1 | 1994 | 1348 | 0.020 |
Why?
|
Emotions | 1 | 2002 | 2642 | 0.020 |
Why?
|
Equipment Design | 2 | 2012 | 3583 | 0.020 |
Why?
|
Analgesics, Opioid | 2 | 2004 | 3650 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 1992 | 450 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3197 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5128 | 0.020 |
Why?
|
Licensure | 1 | 2010 | 124 | 0.020 |
Why?
|
Electrolytes | 1 | 1990 | 282 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 867 | 0.020 |
Why?
|
Locomotion | 1 | 1992 | 379 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8605 | 0.020 |
Why?
|
Vehicle Emissions | 1 | 2014 | 665 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4324 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9336 | 0.020 |
Why?
|
Fourier Analysis | 1 | 1990 | 447 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3614 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12761 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 1999 | 1621 | 0.020 |
Why?
|
Physical Examination | 2 | 1986 | 1231 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2011 | 2732 | 0.020 |
Why?
|
Biometry | 1 | 1992 | 558 | 0.020 |
Why?
|
Selection, Genetic | 1 | 1993 | 915 | 0.020 |
Why?
|
Ultrasonography | 2 | 1993 | 5941 | 0.020 |
Why?
|
Disease Progression | 3 | 2008 | 13237 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2687 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3344 | 0.020 |
Why?
|
Neoplasms | 2 | 2013 | 21507 | 0.020 |
Why?
|
Brain Concussion | 1 | 2019 | 1317 | 0.020 |
Why?
|
Electroencephalography | 1 | 2023 | 6133 | 0.020 |
Why?
|
Computer Communication Networks | 1 | 2010 | 295 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7897 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4269 | 0.020 |
Why?
|
Baltimore | 1 | 2008 | 230 | 0.020 |
Why?
|
Dehydration | 1 | 2009 | 230 | 0.020 |
Why?
|
Propranolol | 1 | 1989 | 499 | 0.020 |
Why?
|
Personal Autonomy | 1 | 2010 | 300 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 1987 | 24 | 0.020 |
Why?
|
Pneumococcal Vaccines | 1 | 2011 | 391 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 2 | 1989 | 2265 | 0.020 |
Why?
|
Fear | 1 | 1996 | 1430 | 0.020 |
Why?
|
Therapeutic Human Experimentation | 1 | 1987 | 42 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 1995 | 932 | 0.020 |
Why?
|
State Government | 1 | 2010 | 371 | 0.020 |
Why?
|
Forearm | 1 | 1989 | 407 | 0.020 |
Why?
|
Isosorbide | 1 | 1986 | 3 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2019 | 1939 | 0.020 |
Why?
|
Swine | 1 | 1997 | 5901 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 1995 | 891 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5462 | 0.020 |
Why?
|
Muscular Atrophy | 1 | 1990 | 346 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1994 | 1356 | 0.020 |
Why?
|
Massage | 1 | 1986 | 85 | 0.020 |
Why?
|
Telephone | 1 | 2010 | 617 | 0.020 |
Why?
|
Alleles | 2 | 1996 | 6942 | 0.020 |
Why?
|
Energy Intake | 1 | 1994 | 2135 | 0.020 |
Why?
|
Confidentiality | 1 | 2010 | 610 | 0.020 |
Why?
|
Prejudice | 1 | 2010 | 572 | 0.020 |
Why?
|
Tissue Donors | 1 | 1995 | 2205 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 488 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2006 | 860 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 641 | 0.020 |
Why?
|
Body Height | 1 | 1992 | 1577 | 0.020 |
Why?
|
Social Class | 1 | 2014 | 1974 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2008 | 1004 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1903 | 0.020 |
Why?
|
Language | 1 | 1994 | 1447 | 0.020 |
Why?
|
Diet | 1 | 2023 | 7876 | 0.020 |
Why?
|
Body Composition | 2 | 2010 | 2397 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3844 | 0.020 |
Why?
|
Valsalva Maneuver | 1 | 2004 | 90 | 0.020 |
Why?
|
Cell Count | 1 | 2008 | 1833 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2010 | 670 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2002 | 2881 | 0.020 |
Why?
|
Water-Electrolyte Balance | 1 | 1985 | 345 | 0.020 |
Why?
|
Cough | 1 | 1987 | 552 | 0.010 |
Why?
|
Mammography | 1 | 1995 | 2466 | 0.010 |
Why?
|
Informed Consent | 1 | 2010 | 988 | 0.010 |
Why?
|
Individuality | 1 | 1985 | 303 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 2032 | 0.010 |
Why?
|
Palliative Care | 1 | 1998 | 3461 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3585 | 0.010 |
Why?
|
Parents | 1 | 2017 | 3368 | 0.010 |
Why?
|
Binomial Distribution | 1 | 2002 | 25 | 0.010 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 1983 | 114 | 0.010 |
Why?
|
Health Expenditures | 1 | 2015 | 2348 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2624 | 0.010 |
Why?
|
Isoenzymes | 1 | 1987 | 1720 | 0.010 |
Why?
|
Gene Deletion | 1 | 2010 | 2757 | 0.010 |
Why?
|
Pressure | 1 | 2005 | 1201 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1995 | 3217 | 0.010 |
Why?
|
Internship and Residency | 1 | 1982 | 5761 | 0.010 |
Why?
|
Memory Disorders | 1 | 2008 | 1183 | 0.010 |
Why?
|
Extracellular Space | 1 | 1983 | 594 | 0.010 |
Why?
|
Peripheral Nerves | 1 | 2002 | 481 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5181 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1983 | 788 | 0.010 |
Why?
|
South Dakota | 1 | 1998 | 31 | 0.010 |
Why?
|
Community Health Centers | 1 | 1982 | 428 | 0.010 |
Why?
|
Kansas | 1 | 1998 | 39 | 0.010 |
Why?
|
Brain Stem | 1 | 1983 | 849 | 0.010 |
Why?
|
Mississippi | 1 | 1998 | 89 | 0.010 |
Why?
|
Diagnosis | 1 | 1999 | 153 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2007 | 1201 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1983 | 927 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1983 | 744 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 1983 | 813 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1990 | 3799 | 0.010 |
Why?
|
Information Systems | 1 | 1999 | 410 | 0.010 |
Why?
|
Polypharmacy | 1 | 1999 | 290 | 0.010 |
Why?
|
Reagent Strips | 1 | 1995 | 39 | 0.010 |
Why?
|
New York | 1 | 1998 | 888 | 0.010 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1995 | 99 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 1995 | 330 | 0.010 |
Why?
|
Drug Therapy | 1 | 1998 | 497 | 0.010 |
Why?
|
Base Sequence | 2 | 1996 | 12804 | 0.010 |
Why?
|
Light | 1 | 1999 | 1380 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 1999 | 1205 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1995 | 10999 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14740 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 18125 | 0.010 |
Why?
|
Physical Endurance | 1 | 1994 | 370 | 0.010 |
Why?
|
Axons | 1 | 1999 | 1689 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 1995 | 529 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1982 | 2711 | 0.010 |
Why?
|
Rats | 1 | 2006 | 24270 | 0.010 |
Why?
|
Weight Lifting | 1 | 1990 | 131 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2006 | 11460 | 0.010 |
Why?
|
Nitroglycerin | 1 | 1990 | 325 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1995 | 766 | 0.010 |
Why?
|
Age of Onset | 1 | 1996 | 3263 | 0.010 |
Why?
|
Hypertrophy | 1 | 1990 | 565 | 0.010 |
Why?
|
Data Collection | 1 | 1998 | 3341 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1996 | 1671 | 0.000 |
Why?
|
Medicaid | 1 | 1999 | 2711 | 0.000 |
Why?
|
Bacteria | 1 | 1995 | 2106 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1999 | 4365 | 0.000 |
Why?
|
Databases, Factual | 1 | 1998 | 7690 | 0.000 |
Why?
|
Mice | 1 | 2006 | 81002 | 0.000 |
Why?
|